ADC Biotechnology Ltd, now Sterling Pharma Solutions' Deeside facility, was founded in 2010 to develop and commercialise next generation conjugation technologies to the Antibody Drug Conjugate market. Find out more at: https://www.sterlingpharmasolutions.com/adcs/